Kappaproct (cobitolimod) - InDex Pharma, Viatris
Tremfya (guselkumab) - J&J
Rinvoq (upadacitinib) - AbbVie
Entyvio (vedolizumab) - Takeda
Velsipity (etrasimod) - Pfizer
tulisokibart (MK-7240) - Merck (MSD)
http://www.ncbi.nlm.nih.gov/pubmed/40468857
 
Fang Hu; Li Xu; Pingting Pan; Qiushuang Li; Shan Liu; Suying Hu; Wenhui Yang; Yingzhe Sun; Youran Dai
 
Jun 5, 2025
 
Next